Why the study?
Does long-term echocardiographic monitoring detect subclinical cardiotoxicity in children treated with anthracyclines for malignancies?
Does long-term echocardiographic monitoring detect subclinical cardiotoxicity in children treated with anthracyclines for malignancies?
Answers are grounded in this paper and cite their sources.
Long-term echocardiographic monitoring aims to detect subclinical cardiotoxicity in children treated with anthracyclines to allow for timely therapeutic intervention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mamić et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: